Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Mouw · SciRah

Researcher profile · Semantic Scholar

K. Mouw

Share profile

K. Mouw — researcher profile on SciRah

h-index: 38
Works: 260
Citations: 6,322

Most-cited papers

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
M. Galsky, S. Daneshmand, S. Izadmehr, Edgar Gonzalez-Kozlova +36 more
2023Nature Medicine145 citations Open access
Semantic Scholar
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer
T. Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui +17 more
2023Nature Communications120 citations Open access
Semantic Scholar
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.
Shilpa Gupta, P. Hensley, Roger Li, A. Choudhury +22 more
2025European Urology50 citations
Semantic Scholar
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.
Kendrick Yim, Kevin R. Melnick, Sarah L. Mott, F. Carvalho +14 more
2023Urologic oncology38 citations
Semantic Scholar
The next chapter in immunotherapy and radiation combination therapy - cancer-specific perspectives.
A. J. Wisdom, C. Barker, Joe Y. Chang, Sandra Demaria +12 more
2024International Journal of Radiation Oncology, Biology, Physics32 citations
Semantic Scholar
Magnetic Resonance–Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental Cohort
J. Leeman, D. Cagney, R. Mak, M. Huynh +11 more
2022Advances in Radiation Oncology32 citations Open access
Semantic Scholar
RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer
Chen-Kui Miao, T. Tsujino, Tomoaki Takai, Fu Gui +9 more
2022Science Advances31 citations Open access
Semantic Scholar
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer
Yu-Zheng Zhou, J. Börcsök, E. Adib, S. Kamran +20 more
2023Science Advances24 citations Open access
Semantic Scholar
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer.
David D. Yang, L. K. Lee, J.M.G. Tsui, J. Leeman +13 more
2024Radiology18 citations
Semantic Scholar
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
S. Kamran, Yu-Zheng Zhou, Keisuke Otani, Michael Drumm +18 more
2023Clinical Cancer Research13 citations Open access
Semantic Scholar
Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Bladder Cancer Models
Yu-Zheng Zhou, V. D'Andrea, Surish P. Shanmugam, I. Stelter +9 more
2024European Urology12 citations Open access
Semantic Scholar
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
B. Huffman, Harshabad Singh, Lestat R. Ali, N. Horick +34 more
2024Journal for ImmunoTherapy of Cancer12 citations Open access
Semantic Scholar
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Justin H. Hwang, Xiao-Lei Shi, A. Elliott, Taylor E. Arnoff +23 more
2023Clinical Cancer Research11 citations Open access
Semantic Scholar
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma
A. Prosz, Haohui Duan, V. Tisza, P. Sahgal +18 more
2023bioRxiv10 citations Open access
Semantic Scholar
DNA Repair Deficiency and the Immune Microenvironment: A Pathways Perspective
Yu-Zheng Zhou, K. Mouw
2023DNA Repair10 citations Open access
Semantic Scholar
Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancer
J. Börcsök, Diyavarshini Gopaul, Daphne Devesa-Serrano, Clémence Mooser +12 more
2025Journal of Clinical Investigation8 citations Open access
Semantic Scholar
CT online adaptive radiotherapy is associated with dosimetric and acute toxicity improvements in prostate cancer treatment.
Lin L. Zhu, J. Bredfeldt, Yue-Houng Hu, C. Hancox +13 more
2025Radiotherapy and Oncology8 citations
Semantic Scholar
ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer
Ilana B. Epstein, A. Odogiyon, Stephanie A. Berg, Yukako S Otani +20 more
2026Clinical Cancer Research7 citations Open access
Semantic Scholar
Impact of DNA repair deficiency on sensitivity to antibody-drug conjugate (ADC) payloads in bladder cancer
Surish P. Shanmugam, Yu-Zheng Zhou, I. Stelter, Timothy Hanlon +4 more
2025Bladder Cancer7 citations Open access
Semantic Scholar
Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma.
K. K. Zarrabi, Abhiraj Saxena, K. Mouw, V. Koshkin +1 more
2025American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting7 citations Open access
Semantic Scholar
Impact of DNA Repair Deficiency in the Evolving Treatment Landscape of Bladder Cancer
V. D'Andrea, C. Magnani, John Ernandez, J. Bellmunt +4 more
2024Current Urology Reports7 citations
Semantic Scholar
Insulin Resistance During Androgen Deprivation Therapy in Men with Prostate Cancer
S. Basaria, M. Taplin, M. Mcdonnell, D. Simonson +29 more
2024Cancer7 citations Open access
Semantic Scholar
Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.
Shilpa Gupta, Roger Li, P. Hensley, S. Daneshmand +17 more
2026European Urology6 citations
Semantic Scholar
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
M. Galsky, S. Daneshmand, S. Izadmehr, Edgar Gonzalez-Kozlova +36 more
2024Nature Medicine5 citations Open access
Semantic Scholar
Urine biopsy as dynamic biomarker to enhance clinical staging of bladder cancer in radical cystectomy candidates
Uttam Satyal, Henkel Valentine, David Liu, M. Slifker +25 more
2024JCO Precision Oncology5 citations
Semantic Scholar
A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.
E. Chandran, Nicholas I. Simon, Scot A Niglio, L. Ley +16 more
2023Journal of Clinical Oncology5 citations Open access
Semantic Scholar
Correlation of circulating tumor DNA (ctDNA) dynamics with clinical response in muscle-invasive bladder cancer (MIBC) patients (pts) undergoing trimodality therapy (TMT).
Ilana B. Epstein, A. Odogiyon, S. Berg, Yukako S Otani +16 more
2025Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1.
P. Hensley, R. Seiler, Harry W. Herr, K. Mouw +9 more
2023Urologic oncology4 citations
Semantic Scholar
Correlation of Circulating Tumor DNA (ctDNA) Dynamics with Clinical Response in Muscle-Invasive Bladder Cancer (MIBC) Patients Undergoing Trimodality Therapy (TMT)
I. Epstein, S. Berg, C. Mantia, M. Mossanen +11 more
2024International Journal of Radiation Oncology, Biology, Physics3 citations
Semantic Scholar
Association Between Artificial Intelligence-Derived Tumor Volume and Oncologic Outcomes for Localized Prostate Cancer Treated with Radiation Therapy
D.-D. Yang, L. K. Lee, J.M.G. Tsui, J. E. Leeman +10 more
2023medRxiv3 citations Open access
Semantic Scholar
Clinical outcomes of de novo versus relapsed early metastatic testicular seminoma treated with contemporary radiation therapy.
D. B. Rosen, Anushka Ghosh, A. Niemierko, C. Beard +9 more
2023International Journal of Radiation Oncology, Biology, Physics3 citations
Semantic Scholar
Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non-Muscle-Invasive Bladder Cancer Progress or Overreach?
A. Kamat, P. Hensley, B. Maiorano, Roger Li +5 more
2026Journal of Clinical Oncology2 citations
Semantic Scholar
Relationship among DNA damage response gene alterations, molecular subtypes, and survival outcomes in patients with metastatic bladder cancer treated on CALGB 90601
G. Iyer, W. Choi, Bin Luo, F. Carvalho +18 more
2025JCO Precision Oncology2 citations Open access
Semantic Scholar
Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancer
Filipe L. F. Carvalho, Jih-Yun Lee, N. Kalavros, Yu-Zheng Zhou +24 more
2025bioRxiv2 citations Open access
Semantic Scholar
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer
D. McConkey, Brian C. Baumann, Stephanie Cooper Greenberg, D. DeGraff +23 more
2024Bladder Cancer2 citations Open access
Semantic Scholar
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.
P. Hensley, J. Teoh, Roger Li, Shilpa Gupta +27 more
2026Nature reviews. Urology1 citations Open access
Semantic Scholar
Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.
K. Mouw, K. Shin, J. Parisi, Bingxu Zhai +14 more
2026Clinical Genitourinary Cancer1 citations
Semantic Scholar
SWOG 2427: Single arm phase II study of bladder preservation with immunoradiotherapy after a clinically meaningful response to neoadjuvant therapy in patients with muscle invasive bladder cancer (BRIGHT).
L. Ballas, Sam Callis, S. Daneshmand, A. Tripathi +12 more
2026Journal of Clinical Oncology1 citations
Semantic Scholar
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes
E. Adib, A. Nassar, S. A. Alaiwi, Sylvan C. Baca +16 more
2026Molecular Cancer Research1 citations
Semantic Scholar
Orthotopic bladder cancer preclinical models: Comprehensive review and technique optimization
Timothy Hanlon, V. D'Andrea, I. Stelter, R. Bekele +2 more
2025Bladder Cancer1 citations Open access
Semantic Scholar
Profiling of early-onset bladder cancer identifies key genomic alterations and potential targets
C. Magnani, V. D'Andrea, Zhi-Yu Qian, John Ernandez +12 more
2025medRxiv1 citations Open access
Semantic Scholar
APOBEC3A-Induced DNA Damage Drives Polymerase θ Dependency and Synthetic Lethality in Cancer
Abhishek Bose, Weisi Liu, Paul Yoo, Alina Sami +15 more
2025bioRxiv1 citations
Semantic Scholar
Circulating Tumor DNA in Urothelial Cancer: Practical Applications in Oncology Clinic.
Kriti Mittal, K. Mouw, Parminder Singh
2025JCO Oncology Practice1 citations
Semantic Scholar
Optimizing local control in the surgical management of bladder cancer
Martin Egger, V. D'Andrea, Clara Steiner, Nnamdi Onochie +6 more
2025Nature reviews. Urology1 citations
Semantic Scholar
Impact of CT Online Adaptive Radiotherapy on Acute Toxicity in Patients Undergoing Prostate Radiotherapy
L.-L. Zhu, J. Bredfeldt, Y.-H. Hu, Y. Lyatskaya +13 more
2024International Journal of Radiation Oncology, Biology, Physics1 citations
Semantic Scholar
Correlation of circulating tumor DNA (ctDNA) dynamics with clinical response in patients with muscle-invasive bladder cancer (MIBC) undergoing trimodality therapy (TMT).
Ilana B. Epstein, S. Berg, C. Mantia, M. Mossanen +11 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Association of ARID1A deficiency with invasive transformation in metastatic bladder cancer.
V. D'Andrea, Timothy Hanlon, Rea Chroneos, R. Bekele +3 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Activity of antibody-drug conjugates (ADCs) with radiation in preclinical bladder cancer models.
V. D'Andrea, Yu-Zheng Zhou, Surish P. Shanmugam, Rea Chroneos +7 more
2024Journal of Clinical Oncology1 citations
Semantic Scholar
MAPK pathway alterations as a targetable vulnerability in bladder cancer.
V. D'Andrea, R. Bekele, Timothy Hanlon, Yu-Zheng Zhou +3 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712
Z. Rana, S. Kamran, A. Shetty, P. Sutera +30 more
2024European Urology Oncology1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Yu-Zheng Zhou×9
Invite
Yu-Zheng Zhou — researcher profile on SciRah
Timothy Hanlon×9
Invite
Timothy Hanlon — researcher profile on SciRah
F. Carvalho×8
Invite
F. Carvalho — researcher profile on SciRah
R. Bekele×8
Invite
R. Bekele — researcher profile on SciRah

×8

Invite

V. D'Andrea — researcher profile on SciRah

Invite

A. Kibel — researcher profile on SciRah

Invite

M. Mossanen — researcher profile on SciRah

Invite

S. Kamran — researcher profile on SciRah

Invite

T. Clinton — researcher profile on SciRah

Ilana B. Epstein×6

Invite

Ilana B. Epstein — researcher profile on SciRah

Invite

I. Stelter — researcher profile on SciRah

Invite

C. Mantia — researcher profile on SciRah